Tripeptidyl pyridinium methyl ketones as potent active site inhibitors of thrombin

Bioorganic and Medicinal Chemistry Letters

Volumn 6, Issue 14, 1996, Pages 1677-1682

  Steinmetzer, Torsten ^a,b   Konishi, Yasuo ^a  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBIN; THROMBIN INHIBITOR; TRIPEPTIDE;

ARTICLE; DRUG DESIGN; DRUG SYNTHESIS; ENZYME BINDING; ENZYME INHIBITION; STRUCTURE ACTIVITY RELATION;

EID: 0030598662     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-894X(96)00291-0     Document Type: Article

References (19)

1. 1. a) Davie, E.W.; Fujikawa, K.; Kisiel, W. Biochemistry 1991, 30, 10363-10370
2. b) Kimball, S.D. Current Pharmaceutical Design 1995, 1, 441-468
3. 2. Bajusz, S.; Szell, E.; Barabas, E.; Bagdy, D. J. Med Chem. 1990, 33, 1729-1735
4. 3. a) Cheng, L.; Goodwin, C.A., Scully, M.F.; Kakkar, V.V.; Claeson, G. J. Med. Chem. 1992, 35, 3364 -3369
5. b) Iwanowicz, E.J.; Lin, J., Roberts, D.G.M.; Michel, I.M.; Seiler, S.M. Bioorganic & Medicinal Chemistry Letters 1992, 2, 1607-1612
6. c) Neises, B.; Tarnus, C.; Broersma, R.J.; Bald, C.; Rémy, J.M.; Heminger, E.F. in: Claeson, G., Scully, M.F., Kakkar, V.V. and Deadman, J., eds. In: The design of synthetic inhibitors of thrombin. Adv. Exp. Med Biol. 1993, 340, 185-188, Plenum Press, New York and London
7. d) Jones, M.D., Atrash, B., Ryder, H., Tegr-Nilsson, A.-C., Gyzander, E., Szelke, M. J. Enzyme Inhibition 1995, 9, 43-60
8. e) Brady, S.F.; Sisko, J.T.; Stauffer, K.J.; Colton, C.D.; Qiu, H.; Lewis, S.D.; Ng, A.S.; Shafer, J.A.; Bogusky, M.J. Bioorg. Med Chem. 1995, 3, 1063-1078
9. 4. Steinmetzer, T.; Silberring, J.; Mrestani-Klaus, C.; Fittkau, S.; Barth, A.; Demuth, H.-U. J. Enzyme Inhibition 1993, 7, 77-85
10. 5. Aplin, R.T.; Christiansen, J.; Young, G.T. Int. J. Peptide Protein Res. 1983, 21, 555-561 In this procedure lithium chloride hydrate in 80% acetic acid instead of hydrogen chloride was used to convert the diazo compound in the chloromethyl ketone, which is probably safer in the presence of the Boc-protecting group.
11. 6. Fittkau, S.; Jahreis, G.; Peters, K. Journal f. prakt. Chemie 1986, 328, 529-538
12. 7. Szewczuk, Z.; Gibbs, B.F.; Yue, S.-Y.; Purisima, E.; Zdanov, A.; Cygler, M.; Konishi, Y. Biochemistry 1992, 31, 9132-9140
13. 13.
14. 9. a) Morrison, J.F. Trends Biochem. Sci. 1982, 7, 102-105
15. b) Morrison, J.F.; Walsh, C.T. Advances in Enzymology 1988, 61, 201-301
16. on [ 1 ] E:1
17. 11. Stone, S.R.; Betz, A.; Hofsteenge, J. Biochemistry 1991, 30, 9841-9848
18. 12. Rehse, P. H.; Steinmetzer, T.; Li, Y.; Konishi, Y.; Cygler, M. Biochemistry 1995, 34, 11537-11544
19. 13. Schultz, R.M.; Varma-Nelson, P.; Ortiz, R.; Kozlowski, K.A.; Orawski; A.T.; Pagast, P.; Frankfater, A. J. Biol. Chem. 1989, 264, 1497-1507